Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Mary Doona
Observed names:
Doona M,
Doona, Mary,
M Doona,
M. Doona
Institutions:
Newcastle upon Tyne Hospitals NHS Foundation Trust,
Newcastle University
Observed institutions:
Royal Victoria Infirmary,
Newcastle upon Tyne Hospitals NHS Foundation Trust,
Newcastle upon Tyne Hospital,
Newcastle University
ORCID:
0000-0001-9533-3745
Observed ORCID:
0000-0001-9533-3745
OpenAlex ID:
A5008156958
Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial
2020
·
Ian Roberts
, Haleema Shakur-Still
, et al.
·
The Lancet
·
404
PDF
Prominent members of the human gut microbiota express endo-acting O-glycanases to initiate mucin breakdown
2020
·
Lucy I. Crouch
, Marcelo V. Liberato
, et al.
·
Nature Communications
·
145
PDF
Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab
2022
·
Simeng Lin
, Nicholas A. Kennedy
, et al.
·
Nature Communications
·
96
PDF
Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study
2022
·
Zhigang Liu
, Kaixing Le
, et al.
·
The Lancet. Gastroenterology & hepatology
·
36
Defining predictors of responsiveness to advanced therapies in Crohn’s disease and ulcerative colitis: protocol for the IBD-RESPONSE and nested CD-metaRESPONSE prospective, multicentre, observational cohort study in precision medicine
2024
·
Nicola J Wyatt
, Hannah Watson
, et al.
·
BMJ Open
·
18
PDF
Clinical Utility and Cost‐Effectiveness of Pretreatment NUDT15 Pharmacogenetic Testing to Prevent Thiopurine‐Induced Myelosuppression: A Genotype‐First Reverse Phenotyping Cohort Study Within the UK NIHR Inflammatory Bowel Disease Bioresource
2025
·
Christopher Roberts
, Jaime Peters
, et al.
·
Alimentary Pharmacology & Therapeutics
·
8
PDF
Evaluation of intestinal biopsy tissue preservation methods to facilitate large-scale mucosal microbiota research
2024
·
Nicola J. Wyatt
, Hannah Watson
, et al.
·
EBioMedicine
·
5
The utility of a symptom model to predict the risk of oesophageal cancer
2022
·
Michael W. Mather
, Janet A. Wilson
, et al.
·
The Surgeon
·
5
PDF
IDEA-FAST clinical study protocol: Identifying digital end-points of fatigue, sleep quality and daytime sleepiness in N = 2000
2026
·
Walter Maetzler
, Stefan Avey
, et al.
·
Digital Health
·
3
Bacterial Dysbiosis Observed in the Terminal Ileum of Ulcerative Colitis
2025
·
Jordan S Mar
, Allen Nguyen
, et al.
·
Inflammatory Bowel Diseases
·
2
PDF
Patient-reported real-world experience of risankizumab on-body device (OBD) for the treatment of Crohn’s disease in the UK (COMMODUS)
2025
·
Adil Jaulim
, Anna Stanton
, et al.
·
Current Medical Research and Opinion
·
2
PDF
P0070 Improvement in quality of life in inflammatory bowel disease patients treated with advanced therapies: Interim findings from IBD-RESPONSE
2026
·
H Watson
, L Beck
, et al.
·
Journal of Crohn s and Colitis
P0184 Improvement in fatigue but not joint pain and stiffness in Inflammatory Bowel Disease patients treated with advanced therapies: Interim findings from IBD-RESPONSE
2026
·
L Beck
, H Watson
, et al.
·
Journal of Crohn s and Colitis
P143 Evaluating intestinal biopsy preservation and storage methods to facilitate large-scale microbiome research in inflammatory bowel disease (IBD)
2024
·
Nicola Wyatt
, Hannah Watson
, et al.
·
Poster presentations
Prominent members of the human gut microbiota express endo-acting O-glycanases to initiate mucin breakdown
2020
·
Lucy I. Crouch
, Marcelo V. Liberato
, et al.
·
Newcastle University ePrints (Newcastle Univesity)
Do Upper Airway Symptoms Predict Gastroesophageal Malignancy?
2015
·
Jason Powell
, Michael Drinnan
, et al.
·
Newcastle University ePrints (Newcastle Univesity)
Clinical Utility and Cost-Effectiveness of Pretreatment NUDT15 Pharmacogenetic Testing to Prevent Thiopurine-Induced Myelosuppression: A Genotype-First Reverse Phenotyping Cohort Study Within the UK NIHR Inflammatory Bowel Disease Bioresource
·
Roberts C
, Peters J
, et al.
·
Newcastle University ePrints (Newcastle Univesity)
PDF
Evaluation of intestinal biopsy tissue preservation methods to facilitate large-scale mucosal microbiota research
·
Wyatt NJ
, Watson H
, et al.
·
Newcastle University ePrints (Newcastle Univesity)
PDF
Show more works
View as search
Works count:
20
Citation count:
724
H-index:
6
I10-index:
5
Year
Topic
Type